Outcomes and hospital admission patterns in patients with diabetes during Ramadan versus a non-fasting period

被引:12
|
作者
Elbarsha, Abdulwahab [1 ,2 ]
Elhemri, Maisoon [1 ]
Lawgaly, Sami A. [1 ]
Rajab, Ashraf [1 ]
Almoghrabi, Badia [1 ]
Elmehdawi, Rafik Ramadan [1 ,2 ]
机构
[1] Benghazi Med Ctr, Dept Med, Second Ring Rd, Foyhat, Benghazi, Libya
[2] Univ Benghazi, Dept Med, Fac Med, Benghazi, Libya
关键词
DISEASE;
D O I
10.5144/0256-4947.2018.344
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Fasting during Ramadan is a challenge for Muslim patients with diabetes and for their healthcare providers. However, data on the effects of Ramadan fasting on hospital admissions and outcomes in patients with diabetes are scarce. OBJECTIVES: Evaluate the characteristics of patients with diabetes admitted during the fasting month of Ramadan compared with the non-fasting month of Dhu al-Qidah. DESIGN: A retrospective cohort study medical record review. SETTING: A university teaching hospital. PATIENTS AND METHODS: We reviewed the records of all patients with diabetes admitted to the medical department at Benghazi Medical Center, including medical ward, intensive care unit and coronary care unit, during the months of Ramadan and Dhu al-Qidah, 2016. We compared differences in reasons for admission, length of stay and in-hospital mortality between patients admitted during Ramadan and Dhu al-Qidah and between patients who were fasting at time of admission during Ramadan and those who were not. MAIN OUTCOME MEASURES: Main reason for admission, length of stay and in-hospital mortality rate. SAMPLE SIZE: 402 patients with diabetes. RESULTS: During Ramadan, 186 patients were admitted compared with 216 during Dhul al-Qidah. There was no statistically significant difference in reasons for admission, length of hospital stay, or in-hospital mortality (borderline for mortality, P=.078), between patients with diabetes admitted during Ramadan and Dhu al-Qidah. Of those admitted in Ramadan, 59.1% were fasting on admission. Fasting patients admitted during Ramadan had a significantly higher proportion of the diseases of the circulatory system when compared with non-fasting patients (39.4% vs. 23.6%, P=.028) while in-hospital mortality was higher in non-fasting patients (29.2% vs. 8.7%, P<.001). There was no significant difference in length of stay between fasting and non-fasting patients. CONCLUSIONS: The frequency of admissions for most medical conditions were not changed during Ramadan but the frequency of acute coronary syndrome was higher in those who were fasting on admission. Patients with diabetes who were not fasting on admission had more high-risk features that prevented them from fasting and therefore are at increased risk of in-hospital mortality. LIMITATIONS: Single center and retrospective.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 50 条
  • [41] Tolerability of canagliflozin in patients with type 2 diabetes fasting during Ramadan: results of the Canagliflozin in RAmadan Tolerance Observational Study (CRATOS)
    Hasanein, M.
    Echtay, A.
    Hassoun, A.
    Alarouj, M.
    Afandi, B.
    Poladian, R.
    Bennakhi, A.
    Nazar, M.
    Bergmans, P.
    Keim, S.
    Hamilton, G.
    Azar, S. T.
    DIABETOLOGIA, 2017, 60 : S405 - S405
  • [42] VIRTUE study: effects of vildagliptin versus sulphonylureas as monotherapy or combined with metformin in Muslim patients with type 2 diabetes fasting during Ramadan
    Shaltout, I.
    Pathan, F.
    Medlej, R.
    Al-Arouj, M.
    Hassoun, A. A. K.
    Chawla, M. S.
    Knap, D.
    Vaz, J. A.
    DIABETOLOGIA, 2014, 57 : S359 - S359
  • [43] Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
    Mohamed Khattab
    Khalifa Mahmoud
    Inass Shaltout
    Diabetes Therapy, 2016, 7 : 551 - 560
  • [44] Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
    Khattab, Mohamed
    Mahmoud, Khalifa
    Shaltout, Inass
    DIABETES THERAPY, 2016, 7 (03) : 551 - 560
  • [45] Fasting during the month of Ramadan among patients with chronic kidney disease: renal and cardiovascular outcomes
    NasrAllah, Mohamed M.
    Osman, Noha A.
    CLINICAL KIDNEY JOURNAL, 2014, 7 (04) : 348 - 353
  • [46] Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan
    Salti, I.
    DIABETIC MEDICINE, 2009, 26 (12) : 1255 - 1261
  • [47] Knowledge of diabetes and the practice of diabetes self-management during Ramadan fasting among patients with type 2 diabetes in Malaysia
    Japar, Salimah
    Ong, Swee Leong
    Muhamed, Zamri
    Fukunaga, Kensaku
    Kobayashi, Toshihiro
    Imachi, Hitomi
    Sato, Seisuke
    Saheki, Takanobu
    Ibata, Tomohiro
    Yoshimura, Takafumi
    Soh, Kim Lam
    Murao, Koji
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (11)
  • [48] Continuous glucose monitoring (CGM) study of patients with diabetes during Ramadan fasting: identifying patients at a higher risk
    Lessan, N.
    Hannoun, Z.
    Hasan, H.
    Barakat, M. T.
    DIABETIC MEDICINE, 2013, 30 : 161 - 161
  • [49] Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study
    Siaw, Melanie Yee Lee
    Chew, Daniel Ek Kwang
    Dalan, Rinkoo
    Shakoor, Shaikh Abdul Kader Kamaldeen Abdul
    Othman, Noorani
    Choo, Chor Hui
    Shamsuri, Nur Hidayah
    Karim, Siti Nurhana Abdul
    Chan, Sui Yung
    Lee, Joyce Yu-Chia
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [50] Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
    Hassanein, Mohamed
    Echtay, Akram
    Hassoun, Ahmed
    Alarouj, Monira
    Afandi, Bachar
    Poladian, Raffi
    Bennakhi, Abdullah
    Nazar, Maciej
    Bergmans, Paul
    Keim, Sofia
    Hamilton, Gill
    Azar, Sami T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (10)